| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | ||||||||||||
7,982 | 7,932 | 7,803 | 7,668 | 5,997 | 4,673 | 4,623 | 4,471 | 4,451 | 4,220 | 4,095 | 4,121 | 3,897 |
Cost of products sold, excluding intangible asset amortization | ||||||||||||
2,252 | 2,271 | 2,132 | 2,381 | 1,800 | 1,242 | 1,266 | 1,125 | 1,122 | 1,012 | 990 | 997 | 875 |
Intangible asset amortization | ||||||||||||
584 | 595 | 603 | 565 | 337 | 92 | 78 | - | - | - | - | - | - |
Gross Profit | ||||||||||||
- | - | - | - | - | - | - | 3,346 | 3,329 | 3,208 | 3,104 | 3,123 | 3,021 |
Research and development | ||||||||||||
449 | 391 | 369 | 365 | 268 | 187 | 203 | 225 | 238 | 218 | 205 | 192 | 182 |
Selling, general and administrative | ||||||||||||
3,343 | 3,379 | 3,104 | 2,944 | 2,284 | 1,750 | 1,749 | 1,807 | 1,834 | 1,759 | 1,729 | 1,704 | 1,516 |
Settlement (Note 17) | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 169 |
Certain claims (Note 20) | ||||||||||||
- | - | - | - | - | 21 | 47 | 15 | 157 | 75 | 35 | 69 | 0 |
Goodwill impairment | ||||||||||||
- | - | - | - | - | - | - | 96 | - | 204 | 73 | - | 0 |
Restructuring and other cost reduction initiatives | ||||||||||||
50 | 34 | 17 | - | - | - | - | - | - | - | - | - | - |
Goodwill and intangible asset impairment | ||||||||||||
70 | 979 | 331 | 31 | - | - | - | - | - | - | - | - | - |
Quality remediation | ||||||||||||
82 | 146 | 181 | 53 | - | - | - | - | - | - | - | - | - |
Acquisition, integration and related | ||||||||||||
12 | 99 | 262 | 504 | - | - | - | - | - | - | - | - | - |
Net curtailment and settlement (Note 14) | ||||||||||||
- | - | - | - | - | - | - | - | - | - | -32 | - | 0 |
Special items (Note 2) | ||||||||||||
- | - | - | - | 839 | 341 | 210 | 155 | 75 | 34 | 75 | 68 | - |
Operating expenses | ||||||||||||
6,844 | 7,899 | 7,004 | 6,847 | 5,530 | 3,636 | 3,554 | 2,299 | 2,305 | 2,291 | 2,085 | 2,033 | 1,894 |
Acquisition, integration, realignment and other (Note 2) | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | - | 25 |
Operating (Loss) Profit | ||||||||||||
1,137 | 33 | 799 | 821 | 467 | 1,037 | 1,068 | 1,047 | 1,024 | 916 | 1,018 | 1,090 | 1,127 |
Other income (expense), net | ||||||||||||
-4 | -15 | -9 | -66 | -36 | -46 | 6 | - | - | - | - | - | - |
Interest income | ||||||||||||
- | - | - | - | 9 | 11 | 15 | 15 | 10 | 3 | 1 | - | - |
Interest expense | ||||||||||||
-226 | -289 | -325 | -355 | 286 | 63 | 70 | 72 | 55 | 60 | 22 | - | - |
(Loss) earnings before income taxes | ||||||||||||
905 | -271 | 464 | 399 | 153 | 939 | 1,008 | 990 | 978 | 860 | 998 | 1,121 | 1,131 |
Interest and other income (expense), net | ||||||||||||
- | - | - | - | - | - | - | - | - | - | - | 31 | 4 |
Provision for income taxes | ||||||||||||
-225 | 108 | -1,348 | 95 | 7 | 220 | 229 | 237 | 218 | 263 | 280 | 272 | 357 |
Net (Loss) Earnings | ||||||||||||
1,131 | -379 | 1,813 | 304 | 146 | 719 | 778 | 752 | 760 | 596 | 717 | 849 | 773 |
Less: Net (loss) earnings attributable to noncontrolling interest | ||||||||||||
-0 | -0 | -0 | -1 | -0 | -1 | -1 | -2 | -0 | - | - | 0 | 0 |
Net (Loss) Earnings of Zimmer Biomet Holdings, Inc. | ||||||||||||
1,131 | -379 | 1,813 | 305 | 147 | 720 | 780 | 755 | 760 | 596 | 717 | 848 | 773 |
(Loss) Earnings Per Common Share | ||||||||||||
Basic | ||||||||||||
5.52 | -1.86 | 8.98 | 1.53 | 0.78 | 4.26 | 4.60 | 4.32 | 4.05 | 2.98 | 3.34 | 3.73 | 3.28 |
Diluted | ||||||||||||
5.47 | -1.86 | 8.90 | 1.51 | 0.77 | 4.20 | 4.54 | 4.29 | 4.03 | 2.97 | 3.32 | 3.72 | 3.26 |
Weighted Average Common Shares Outstanding | ||||||||||||
Basic | ||||||||||||
205 | 203 | 201 | 200 | 187 | 169 | 169 | 174 | 187 | 200 | 215 | 227 | 235 |
Diluted | ||||||||||||
206 | 203 | 203 | 202 | 189 | 171 | 171 | 176 | 188 | 201 | 215 | 228 | 237 |
Cash Dividends Declared Per Common Share | ||||||||||||
- | - | - | - | 0.88 | 0.88 | 0.80 | 0.54 | 0.18 | - | - | - | - |